Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis

Translational Research

Volumn 166, Issue 3, 2015, Pages 292-303

  Choi, Hyo Sun ^a   Kang, Jung Woo ^a   Lee, Sun Mee ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; EARLY GROWTH RESPONSE FACTOR 1; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 33; MACROPHAGE INFLAMMATORY PROTEIN 2; MELATONIN; MESSENGER RNA; MIXED LINEAGE KINASE; MIXED LINEAGE KINASE DOMAIN LIKE PROTEIN; OLIVE OIL; PATTERN RECOGNITION RECEPTOR; PROTEIN; RECEPTOR INTERACTING PROTEIN 1; RECEPTOR INTERACTING PROTEIN 3; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, RAT; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FIBROGENESIS; IMMUNOPRECIPITATION; LIVER; LIVER CELL DAMAGE; MALE; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; ANIMAL; APOPTOSIS; BLOOD; DRUG EFFECTS; LIVER CELL; LIVER CIRRHOSIS; METABOLISM; NECROSIS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; HEPATOCYTES; HMGB1 PROTEIN; INTERLEUKIN-1ALPHA; INTERLEUKINS; LIVER CIRRHOSIS; MALE; MELATONIN; NECROSIS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84938989183     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.04.002     Document Type: Article

References (59)

1. H. Bantel, A. Lugering, J. Heidemann, and et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury Hepatology 40 2004 1078 1087
2. L.W. Weber, M. Boll, and A. Stampfl Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model Crit Rev Toxicol 33 2003 105 136
3. A. Mitra, A. Satelli, J. Yan, and et al. IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice Hepatology 60 2014 2027 2039
4. D.E. Christofferson, and J. Yuan Necroptosis as an alternative form of programmed cell death Curr Opin Cell Biol 22 2010 263 268
5. C.C. Smith, S.M. Davidson, S.Y. Lim, J.C. Simpkin, J.S. Hothersall, and D.M. Yellon Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther 21 2007 227 233
6. P.S. Welz, A. Wullaert, K. Vlantis, and et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation Nature 477 2011 330 334
7. D.W. Zhang, J. Shao, J. Lin, and et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis Science 325 2009 332 336
8. S. He, L. Wang, L. Miao, and et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha Cell 137 2009 1100 1111
9. S. Roychowdhury, M.R. McMullen, S.G. Pisano, X. Liu, and L.E. Nagy Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury Hepatology 57 2013 1773 1783
10. J. Gautheron, M. Vucur, F. Reisinger, and et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis EMBO Mol Med 6 2014 1062 1074
11. K. Takemoto, E. Hatano, K. Iwaisako, and et al. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure FEBS Open Bio 4 2014 777 787
12. A. Kovalenko, J.C. Kim, T.B. Kang, and et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease J Exp Med 206 2009 2161 2177
13. A. Lau, S. Wang, J. Jiang, and et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival Am J Transplant 13 2013 2805 2818
14. A. Pavlosky, A. Lau, Y. Su, and et al. RIPK3-mediated necroptosis regulates cardiac allograft rejection Am J Transplant 14 2014 1778 1790
15. R. Hardeland, J.A. Madrid, D.X. Tan, and R.J. Reiter Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling J Pineal Res 52 2012 139 166
16. R.J. Reiter, D.X. Tan, and L. Fuentes-Broto Melatonin: a multitasking molecule Prog Brain Res 181 2010 127 151
17. C. Venegas, J.A. Garcia, C. Doerrier, and et al. Analysis of the daily changes of melatonin receptors in the rat liver J Pineal Res 54 2013 313 321
18. E. Sewerynek, R.J. Reiter, D. Melchiorri, G.G. Ortiz, and A. Lewinski Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin Hepatogastroenterology 43 1996 898 905
19. S.H. Kim, and S.M. Lee Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia/reperfusion injury in rat liver J Pineal Res 44 2008 165 171
20. I. Grigorov, D. Bogojevic, S. Jovanovic, and et al. Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats J Physiol Biochem 70 2014 441 450
21. Z. Wang, L. Wu, W. You, C. Ji, and G. Chen Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway J Pineal Res 55 2013 399 408
22. J.W. Kang, H.I. Cho, and S.M. Lee Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion Cell Physiol Biochem 33 2014 23 36
23. J.B. Chakraborty, F. Oakley, and M.J. Walsh Mechanisms and biomarkers of apoptosis in liver disease and fibrosis Int J Hepatol 2012 2012 648915
24. J. Han, C.Q. Zhong, and D.W. Zhang Programmed necrosis: backup to and competitor with apoptosis in the immune system Nat Immunol 12 2011 1143 1149
25. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer Molecular mechanisms of necroptosis: an ordered cellular explosion Nat Rev Mol Cell Biol 11 2010 700 714
26. G. Tahan, H. Akin, F. Aydogan, and et al. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats Can J Surg 53 2010 313 318
27. V. Tahan, R. Ozaras, B. Canbakan, and et al. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats J Pineal Res 37 2004 78 84
28. A. Cruz, F.J. Padillo, E. Torres, and et al. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats J Pineal Res 39 2005 143 150
29. 2-induced activation of rat hepatic stellate cells J Pineal Res 41 2006 275 278
30. Y. Ohta, M. Kongo-Nishimura, T. Matsura, K. Yamada, A. Kitagawa, and T. Kishikawa Melatonin prevents disruption of hepatic reactive oxygen species metabolism in rats treated with carbon tetrachloride J Pineal Res 36 2004 10 17
31. M. Ogeturk, I. Kus, H. Pekmez, H. Yekeler, S. Sahin, and M. Sarsilmaz Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis Toxicol Ind Health 24 2008 201 208
32. I. Crespo, B. San-Miguel, A. Fernandez, J. Ortiz de Urbina, J. Gonzalez-Gallego, and M.J. Tunon Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice Transl Res 165 2015 346 357
33. D.A. Story Postoperative mortality and complications Best Pract Res Clin Anaesthesiol 25 2011 319 327
34. E. Marcolin, B. San-Miguel, D. Vallejo, and et al. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis J Nutr 142 2012 1821 1828
35. A. Zhang, X. Mao, L. Li, and et al. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury Transpl Int 27 2014 1077 1085
36. S. Jouan-Lanhouet, M.I. Arshad, C. Piquet-Pellorce, and et al. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation Cell Death Differ 19 2012 2003 2014
37. S.I. McNeal, M.P. LeGolvan, C.S. Chung, and A. Ayala The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis Shock 35 2011 499 505
38. D.M. Rosenbaum, A. Degterev, J. David, and et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model J Neurosci Res 88 2010 1569 1576
39. F.K. Chan, J. Shisler, J.G. Bixby, and et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses J Biol Chem 278 2003 51613 51621
40. X. Yu, Q. Deng, W. Li, and et al. Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFalpha and ROS production Oncotarget 6 2015 1995 2008
41. A. Tsung, R. Sahai, H. Tanaka, and et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion J Exp Med 201 2005 1135 1143
42. A.B. Imaeda, A. Watanabe, M.A. Sohail, and et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J Clin Invest 119 2009 305 314
43. M.T. Lotze, and K.J. Tracey High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342
44. T. Bonaldi, F. Talamo, P. Scaffidi, and et al. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion EMBO J 22 2003 5551 5560
45. R.R. Zhou, S.S. Zhao, M.X. Zou, and et al. HMGB1 cytoplasmic translocation in patients with acute liver failure BMC Gastroenterol 11 2011 21
46. J. Schmitz, A. Owyang, E. Oldham, and et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
47. J.A. Rickard, J.A. O'Donnell, J.M. Evans, and et al. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis Cell 157 2014 1175 1188
48. H. England, H.R. Summersgill, M.E. Edye, N.J. Rothwell, and D. Brough Release of interleukin-1alpha or interleukin-1beta depends on mechanism of cell death J Biol Chem 289 2014 15942 15950
49. J.R. Lukens, P. Vogel, G.R. Johnson, and et al. RIP1-driven autoinflammation targets IL-1alpha independently of inflammasomes and RIP3 Nature 498 2013 224 227
50. V. Carriere, L. Roussel, N. Ortega, and et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci U S A 104 2007 282 287
51. Y.H. Kao, Y.C. Lin, M.S. Tsai, and et al. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis Biochim Biophys Acta 1842 2014 1720 1732
52. R.G. Gieling, K. Wallace, and Y.P. Han Interleukin-1 participates in the progression from liver injury to fibrosis Am J Physiol Gastrointest Liver Physiol 296 2009 G1324 G1331
53. L. Ji, R. Xue, W. Tang, and et al. Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-kappaB signaling pathways FEBS Lett 588 2014 2095 2100
54. E. Seki, S. De Minicis, C.H. Osterreicher, and et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332
55. T. Luedde, and R.F. Schwabe NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma Nat Rev Gastroenterol Hepatol 8 2011 108 118
56. K. Schultz, V. Murthy, J.B. Tatro, and D. Beasley Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol 292 2007 H2927 H2934
57. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955
58. X.G. Cai, J.R. Xia, W.D. Li, and et al. Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis Mol Med Rep 10 2014 306 314
59. Y. Xu, F. Toure, W. Qu, and et al. Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages J Biol Chem 285 2010 23233 23240